A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia

Blood

Volumn 94, Issue 9, 1999, Pages 3015-3021

  Sanz, Miguel A ^a   Martín, Guillermo ^b   Rayón, Consuelo ^b   Esteve, Jordi ^b   González, Marcos ^b   Díaz Mediavilla, Joaquín ^b   Bolufer, Pascual ^b   Barragán, Eva ^b   Terol, María J ^b   González, José D ^b   Colomer, Dolors ^b   Chilión, Carmen ^b   Rivas, Concha ^b   Gómez, Teresa ^b   Ribera, José M ^b   Bornstein, Rafael ^b   Román, José ^b   Calasanz, María J ^b   Arias, Jesus ^b   Álvarez, Carmen ^b   Ramos, Fernando ^b   Debén, Guillermo ^b   more..

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FIBRINOGEN; FRESH FROZEN PLASMA; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID; RETINOIC ACID RECEPTOR; TRANEXAMIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER REGRESSION; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETINOIC ACID SYNDROME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TOXICITY; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; TREATMENT OUTCOME; TRETINOIN;

EID: 0033230342     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Miller WH Jr, Kakizuka A, Frankel SR, Warrell RP Jr, DeBlasio A, Levine K, Evans RM, Dmitrovsky E: Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89:2694, 1992
2. Slack JL: Recent advances in the biology and treatment of acute promyelocytic leukemia. Educational Book of the 34th Meeting of the American Society of Clinical Oncology, Los Angeles, CA, 1998, p 54
3. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willenze R, Muus P, Pelicci PG, Biondi A, Lo Coco F: Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 90:1014, 1997
4. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz MA, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E, Dombret H, Chastang C, Degos L, and the European APL 91 Group: Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 82:3241, 1993
5. Frankel SR, Eardley A, Heller G, Berman E, Miller WH Jr, Dmitrvsky E, Warrell RP Jr: All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann Intern Med 120:278, 1994
6. Burnett AK, Goldstone AH, Gray RG, Wheatley K, on behalf of the UK MRC Adult Leukemia Working Party: All-trans retinoic acid given concurrently with induction chemotherapy improves the outcome of APL: Results of the UK MRC ATRA trial. Blood 90: 330a, 1997 (abstr)
7. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman CL, Bloomfield CD, Rowe JM, Wiernick PH: All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 337:1201, 1997
8. Asou N, Adachi K, Tamura J, Kanamuru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama K, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake S, Suzushima H, Emi N, and Ohno R for the Japan Adult Leukemia Study Group: Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. J Clin Oncol 16:78, 1998
9. Fenaux P, Chastang C, Sanz MA, Dombret H, Archimbaud E, Jacky E, Fey M, Rayón C, Huguet F, Sotto JJ, Gardin C, Reiffers J, Travade P, Solary E, Fegueux N, Bordessoule D, San Miguel J, Link H, Desablens B, Tilly H, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L for the European APL Group: A randomized comparison of ATRA followed by chemotherapy and ATRA plus chemotherapy, and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood (in press)
10. Head D, Kopecky KJ, Weick J, Files JC, Ryan D, Foucar K, Montiel M, Bickers J, Fishleder A, Miller M: Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood 85:1717, 1995
11. Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon MF: Acute promyelocytic leukemia: Results of treatment by daunorobicin. Blood 41:489, 1973
12. Sanz MA, Jarque I, Martín G, Lorenzo I, Martínez J, Rafecas J, Pastor E, Sayas MJ, Sanz G, Gomis F: Acute promyelocytic leukemia. Therapy results and prognostic factors. Cancer 61:7, 1988
13. Petti MC, Avvisati G, Amadori S, Baccarani M, Guarini AR, Papa G, Rosti GA, Tura S, Mandelli F: Acute promyelocytic leukemia: Clinical aspects and results of treatment in 62 patients. Haematologica 72:151, 1987
14. Marty M, Ganem G, Fischer J, Flandrin G, Berger R, Schaison G, Degos L: Leucémie aigue promyelocitaire: étude retrospective de 119 malades traités par daunorubicine. Nouv Rev Fr Hematol 26:371, 1984
15. Avvisati G, Mandelli F, Petti MC, Vegna ML, Spadea A, Liso V, Specchia G, Bernasconi C, Alessandrino EP, Piatti C, Carella AM: Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: A pilot study of the Italian cooperative group GIMEMA. Eur J Haematol 44:257, 1990
16. Estey E, Thall PF, Pierce S, Kantarjian H, Keating M: Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. J Clin Oncol 15:483, 1997
17. Diverio D, Rossi V, Avvisati G, DeSantis S, Pistilli A, Pane F, Saglio G, Martinelli G, Petti MC, Santoro A, Pelicci PG, Mandelli F, Biondi A, Lo Coco F: Early detection of relapse by prospective RT-PCR analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. Blood 92:784, 1998
18. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrel RP Jr: The 'retinoic acid syndrome' in acute promyelocytic leukemia. Ann Intern Med 117:292, 1992
19. Bolufer P, Barragán E, Sanz MA, Martín G, Bornstein R, Colomer D, Delgado MD, González M, Marugán I, Román J, Gómez MT, Anguita E, Diverio D, Chomienne Ch, Briz M: Preliminary experience in external quality control of RT-PCR PML/RARα detection in promyelocytic leukemia. Leukemia 12:2024, 1998
20. Biondi A, Rambaldi A, Pandolfi PP, Rosi V, Giudici G, Alcalay M, Lo Coco F, Diverio D, Pogliani EM, Lanzi EM: Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 80:492, 1992
21. Borrow J, Goddard AD, Gibbons B, Katz F, Swirsky D, Fioretos T, Dube I, Windfield DA, Kingston J, Hagemeijer A: Diagnosis of acute promyelocytic leukaemia by RT-PCR: Detection of PML-RARα and RARα-PML fusion transcripts. Br J Haematol 82:529, 1992
22. Falini B, Flenghi L, Fagioli M, Lo Coco F, Cordone I, Diverio D, Pasqualucci L, Biondi A, Riganelli D, Orleth A, Liso A, Martelli MF, Pelicci PG, Pileri S: Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the anti-PML monoclonal antibody PG-M3. Blood 90:4046, 1997
23. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ: Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8:813, 1990
24. Kaplan EL, Meier P: Nonparametric estimations from incomplete observations. J Am Stat Assoc 53:457, 1958
25. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
26. Harrington D, Fleming TR: A class of rank test procedures for censored survival data. Biometrika 69:133, 1982
27. Harrington D, Fleming TR: Counting Processes and Survival Analysis. New York, NY, Wiley, 1991
28. Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH: Presenting white cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Results of the randomized MRC trial. Blood 93:4131, 1999